Generic drug
Liraglutide price, strengths & recalls
Pharmacies pay $257.25 for 9 mL of Liraglutide 6 mg/mL, 3 mL pen this week, and from $257.25 to $709.00 across its 2 priced strengths and forms. 11 manufacturers make it. It is in shortage (limited availability). 1 recall is ongoing. Its official label last changed on November 2, 2026.
Limited availability1 open recallGeneric- Fair cash price
- $306.34
- Strengths
- 2
- Makers
- 11
- Updated
- Nov 11
Liraglutide price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 6 mg/mL pen | $47.27 | $709.00 / 15 mL |
| 6 mg/mL, 3 mL pen | $28.58 | $257.25 / 9 mL |
Brand names of liraglutide
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)
- Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)Estimated shortage duration: TBD
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)Distributed by Teva
- Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)Estimated shortage duration: TBD
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)Distributed by Teva
- Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
- Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)
- Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
- Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Liraglutide
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION.LIRAGLUTIDE injection, for subcutaneous useInitial U.S. Approval: 2010
WARNING: RISK OF THYROID C-CELL TUMORS
WARNING: RISK OF THYROID C-CELL TUMORS
Liraglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether liraglutide injection causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), Nonclinical Toxicology (13.1)].
Liraglutide injection is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk for MTC with the use of liraglutide injection and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with liraglutide injection [see Contraindications (4), Warnings and Precautions (5.1)].
WARNING: RISK OF THYROID C-CELL TUMORS
See full prescribing information for complete boxed warning.
• Liraglutide causes thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether liraglutide injection causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1).
• Liraglutide injection is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and the symptoms of thyroid tumors (4, 5.1).
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Indications and Usage. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . 05/2025
Warnings and Precautions
Severe Gastrointestinal Adverse Reactions (5.6) . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . .. . . . . 10/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022341 · Novo Nordisk Inc
- First approved
- January 25, 2010 (16 years ago)
- Latest approved change
- October 14, 2025
- Approved label
- PDF, Oct 15, 2025
- Generic makers
- 8 approved generic applications on the market
- Last patent listed
- July 9, 2037
Liraglutide questions
How much does liraglutide cost without insurance?
Pharmacies pay about $257.25 for 9 mL of liraglutide 6 mg/mL, 3 mL pen ($28.58 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $306.34. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of liraglutide?
Is liraglutide in shortage?
Yes. 10 products are listed as in shortage or being discontinued (limited availability). See which ones.
Has liraglutide been recalled?
3 recalls on record, 1 ongoing. Recalls name specific lots - check yours.
When did the liraglutide label last change?
The official label was last updated on November 2, 2026 (version 11). See what changed.
Talk about liraglutide
No comments yet. Questions, tips, what worked for you - start the conversation.